If there was a takeover imminent subject to FDA approval, how do you see this process playing out? For example, does the stock remain in a Trading Halt to receive the FDA decision, and then if positive, deal with the potential takeover all whilst remaining in a trading halt, or does the trading halt cease once the approval is received thus allowing further trading to occur, before going into another trading halt thereafter to deal with the pending takeover negotiations?
Also, would this be the case if there was a Licensing deal on the table as potentially suggested by NZT?
BOT - Anything but charting, page-8484
-
- There are more pages in this discussion • 435 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |